Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial
- 1 March 1996
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 32 (2) , 123-131
- https://doi.org/10.1016/s0163-4453(96)91312-2
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Clinical Manifestations of AIDS in the Era of Pneumocystis ProphylaxisNew England Journal of Medicine, 1993
- Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDSThe Lancet, 1991
- The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) InfectionAnnals of Internal Medicine, 1990
- The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Prophylaxis of Pneumocystis carinii Pneumonia: An UpdateThe Journal of Infectious Diseases, 1989
- From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virusPublished by American Medical Association (AMA) ,1989
- Treatment of Infections Associated with Human Immunodeficiency VirusNew England Journal of Medicine, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Pulmonary Complications of the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984
- Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other ImmunodeficienciesAnnals of Internal Medicine, 1984